News Buzz: Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), Rite Aid Corporation (NYSE:RAD), Yelp Inc. (NYSE:YELP), PS Business Parks Inc. (NYSE:PSB), Kite Pharma, Inc. (NASDAQ:KITE)

Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) belongs to Healthcare sector. Its weekly performance is -16.79%. On last trading day company shares ended up $10.26. Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) distance from 50-day simple moving average (SMA50) is -22.11%. On 29 June, Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE) announced top-line clinical efficacy results from the metformin arm of an ongoing Phase 2 proof-of-concept clinical trial of BI187004/VTP-34072 in the treatment of overweight type 2 diabetic patients. BI187004/VTP-34072 is a potential first-in-class 11β-hydroxysteroid dehydrogenase type 1 (11β HSD1) inhibitor that was discovered by Vitae and is currently being developed by Boehringer Ingelheim GmbH (Boehringer Ingelheim), a leader in diabetes treatments and cardiometabolic research and development.

Rite Aid Corporation (NYSE:RAD) shares increased 0.35% in last trading session and ended the day at $8.71. RAD Gross Margin is 28.60% and its return on assets is 24.90%. Rite Aid Corporation (NYSE:RAD) quarterly performance is 4.31%. On 2 July, Rite Aid Corporation (NYSE:RAD) said that sales at established stores rose 2.4% during June, again led by growth in the pharmacy section.

Yelp Inc. (NYSE:YELP) shares moved down -0.06% in last trading session and ended the day at $34.73. YELP Gross Margin is 93.30% and its return on assets is 6.10%. Yelp Inc. (NYSE:YELP) quarterly performance is -27.11%.On 3 July, Yelp Inc. (NYSE:YELP) had temporarily decided not to pursue a sale.

PS Business Parks Inc. (NYSE:PSB) ended the last trading day at $73.96. Company weekly volatility is calculated as 2.00% and price to cash ratio as 10.60. PS Business Parks Inc. (NYSE:PSB) showed a weekly performance of 1.48%. PS Business Parks Inc. (NYSE:PSB) announced that it intends to release its second quarter 2015 earnings after the close of business on Tuesday, July 28, 2015.

Kite Pharma, Inc. (NASDAQ:KITE) shares increased 1.66% in last trading session and ended the day at $64.36. KITE return on assets is -18.60%. Kite Pharma, Inc. (NASDAQ:KITE) quarterly performance is 10.32%.Zacks upgraded shares of Kite Pharma, Inc. (NASDAQ:KITE) from a sell rating to a hold rating in a report released on Monday.

Leave a Reply

Your email address will not be published. Required fields are marked *